On The Blog
DEA Is Expected to Extend Telemedicine Prescribing Flexibilities Through 2025
Nov 06, 2024
Continue Reading...
Following significant pressure from both Congress and the White House, the DEA submitted a proposed rule on October 11, 2024, aimed at maintaining telemedicine prescribing flexibilities for controlled substances. Although the details of this rule have not been disclosed, it is anticipated that...